Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

305 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combination of quinine as a potential reversing agent with mitoxantrone and cytarabine for the treatment of acute leukemias: a randomized multicenter study.
Solary E, Witz B, Caillot D, Moreau P, Desablens B, Cahn JY, Sadoun A, Pignon B, Berthou C, Maloisel F, Guyotat D, Casassus P, Ifrah N, Lamy Y, Audhuy B, Colombat P, Harousseau JL. Solary E, et al. Among authors: ifrah n. Blood. 1996 Aug 15;88(4):1198-205. Blood. 1996. PMID: 8695837 Free article. Clinical Trial.
Double-intensive therapy in high-risk multiple myeloma.
Harousseau JL, Milpied N, Laporte JP, Collombat P, Facon T, Tigaud JD, Casassus P, Guilhot F, Ifrah N, Gandhour C. Harousseau JL, et al. Among authors: ifrah n. Blood. 1992 Jun 1;79(11):2827-33. Blood. 1992. PMID: 1350228 Free article.
Double intensive consolidation chemotherapy (ICC) for acute myeloid leukemia.
Harousseau JL, Milpied N, Briere J, Desablens B, Le Prise PY, Ifrah N, Gandhour C, Casassus P. Harousseau JL, et al. Among authors: ifrah n. Haematol Blood Transfus. 1990;33:299-303. doi: 10.1007/978-3-642-74643-7_54. Haematol Blood Transfus. 1990. PMID: 2323633 No abstract available.
Quinine improves the results of intensive chemotherapy in myelodysplastic syndromes expressing P glycoprotein: results of a randomized study.
Wattel E, Solary E, Hecquet B, Caillot D, Ifrah N, Brion A, Mahé B, Milpied N, Janvier M, Guerci A, Rochant H, Cordonnier C, Dreyfus F, Buzyn A, Hoang-Ngoc L, Stoppa AM, Gratecos N, Sadoun A, Stamatoulas A, Tilly H, Brice P, Maloisel F, Lioure B, Desablens B, Fenaux P, et al. Wattel E, et al. Among authors: ifrah n. Br J Haematol. 1998 Sep;102(4):1015-24. doi: 10.1046/j.1365-2141.1998.00870.x. Br J Haematol. 1998. PMID: 9734653 Free article. Clinical Trial.
Quinine improves results of intensive chemotherapy (IC) in myelodysplastic syndromes (MDS) expressing P-glycoprotein (PGP). Updated results of a randomized study. Groupe Français des Myélodysplasies (GFM) and Groupe GOELAMS.
Wattel E, Solary E, Hecquet B, Caillot D, Ifrah N, Brion A, Milpied N, Janvier M, Guerci A, Rochant H, Cordonnier C, Dreyfus F, Veil A, Hoang-Ngoc L, Stoppa AM, Gratecos N, Sadoun A, Tilly H, Brice P, Lioure B, Desablens B, Pignon B, Abgrall JP, Leporrier M, Fenaux P, et al. Wattel E, et al. Among authors: ifrah n. Adv Exp Med Biol. 1999;457:35-46. doi: 10.1007/978-1-4615-4811-9_5. Adv Exp Med Biol. 1999. PMID: 10500778 Clinical Trial.
Intensive short term therapy with granulocyte-macrophage-colony stimulating factor support, similar to therapy for acute myeloblastic leukemia, does not improve overall results for adults with acute lymphoblastic leukemia. GOELAMS Group.
Ifrah N, Witz F, Jouet JP, François S, Lamy T, Linassier C, Pignon B, Berthou C, Guyotat D, Cahn JY, Harousseau JL. Ifrah N, et al. Cancer. 1999 Oct 15;86(8):1496-505. doi: 10.1002/(sici)1097-0142(19991015)86:8<1496::aid-cncr16>3.0.co;2-#. Cancer. 1999. PMID: 10526278 Clinical Trial.
305 results